ClinicalTrials.Veeva

Menu

Safety Study of the Rapid System for Acute Ischemic Stroke

R

Rapid Medical

Status and phase

Completed
Phase 1

Conditions

Acute Ischemic Stroke

Treatments

Device: Rapid System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01404403
002-07-01-RR

Details and patient eligibility

About

This is a safety study of the Rapid System for acute ischemic stroke.

Enrollment

12 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥18 to <85 years old
  • Pre stroke modified Rankin Scale (mRS) of ≤2
  • A signed informed consent by patient or a legally acceptable representative

Exclusion criteria

  • Pre-stroke life expectancy of less than 6 months
  • Current participation in another investigational drug or device study
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Stroke patients
Other group
Treatment:
Device: Rapid System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems